Viewing Study NCT06716905


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2025-12-26 @ 2:03 AM
Study NCT ID: NCT06716905
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2024-11-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants
Sponsor: Xiamen Amoytop Biotech Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-03-06
Start Date Type: ACTUAL
Primary Completion Date: 2025-09-22
Primary Completion Date Type: ACTUAL
Completion Date: 2025-12
Completion Date Type: ESTIMATED
First Submit Date: 2024-11-13
First Submit QC Date: None
Study First Post Date: 2024-12-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-13
Last Update Post Date: 2025-11-17
Last Update Post Date Type: ESTIMATED